These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2095926)

  • 81. Endometrial evaluation by ultrasonography, hysteroscopy and histopathology in cases of breast carcinoma on Tamoxifen therapy.
    Jindal A; Mohi MK; Kaur M; Kaur B; Singla R; Singh S
    J Midlife Health; 2015; 6(2):59-65. PubMed ID: 26167055
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: a mechanism accounting for the cardioprotective action of tamoxifen?
    Wiseman H; Paganga G; Rice-Evans C; Halliwell B
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):635-8. PubMed ID: 8317992
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal women.
    Esteva FJ; Hortobagyi GN
    Breast; 2006 Jun; 15(3):301-12. PubMed ID: 16230014
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Serum cholesterol reduction with tamoxifen.
    Schapira DV; Kumar NB; Lyman GH
    Breast Cancer Res Treat; 1990 Nov; 17(1):3-7. PubMed ID: 2095926
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The effect of tamoxifen treatment on serum cholesterol fractions in breast cancer women.
    Dziewulska-Bokiniec A; Wojtacki J; Skokowski J; Kortas B
    Neoplasma; 1994; 41(1):13-6. PubMed ID: 8202188
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Plasma levels of the atherogenic amino acid homocysteine in post-menopausal women with breast cancer treated with tamoxifen.
    Anker G; Lønning PE; Ueland PM; Refsum H; Lien EA
    Int J Cancer; 1995 Jan; 60(3):365-8. PubMed ID: 7829246
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Level of total cholesterol in serum of patients with breast cancer treated with tamoxifen].
    Wojtacki J; Dziewulska-Bokiniec A
    Pol Tyg Lek; 1993 Jun 7-14; 48(23-24):505-6. PubMed ID: 8170824
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Plasma lipids and lipoprotein alterations in tamoxifen-treated breast cancer women in relation to the menopausal status.
    Ilanchezhian S; Thangaraju M; Sachdanandam P
    Cancer Biochem Biophys; 1995 Nov; 15(2):83-90. PubMed ID: 8590439
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Early menopause and the risk of myocardial infarction.
    Rosenberg L; Hennekens CH; Rosner B; Belanger C; Rothman KJ; Speizer FE
    Am J Obstet Gynecol; 1981 Jan; 139(1):47-51. PubMed ID: 7457520
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen.
    Rössner S; Wallgren A
    Atherosclerosis; 1984 Sep; 52(3):339-46. PubMed ID: 6497936
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effects of an antiestrogen on subfractions of HDL cholesterol during estrogen replacement therapy.
    Ottosson UB; Carlström K; Johansson BG; von Schoultz B
    Gynecol Obstet Invest; 1984; 18(3):140-6. PubMed ID: 6436151
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Current status of the cholesterol controversy.
    Levy RI
    Am J Med; 1983 May; 74(5A):1-4. PubMed ID: 6342382
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Consensus conference. Adjuvant chemotherapy for breast cancer.
    JAMA; 1985 Dec; 254(24):3461-3. PubMed ID: 4068189
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Coronary risk prediction in adults (the Framingham Heart Study).
    Wilson PW; Castelli WP; Kannel WB
    Am J Cardiol; 1987 May; 59(14):91G-94G. PubMed ID: 3591674
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cardiovascular and risk factor evaluation of healthy American adults. A statement for physicians by an Ad Hoc Committee appointed by the Steering Committee, American Heart Association.
    Grundy SM; Greenland P; Herd A; Huebsch JA; Jones RJ; Mitchell JH; Schlant RC
    Circulation; 1987 Jun; 75(6):1340A-1362A. PubMed ID: 3552309
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels.
    Bertelli G; Pronzato P; Amoroso D; Cusimano MP; Conte PF; Montagna G; Bertolini S; Rosso R
    Breast Cancer Res Treat; 1988 Dec; 12(3):307-10. PubMed ID: 3228593
    [TBL] [Abstract][Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.